LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Search

Retractable Technologies Inc

Closed

SectorHealthcare

0.84 2.44

Overview

Share price change

24h

Current

Min

0.8

Max

0.85

Key metrics

By Trading Economics

Income

10M

-87K

Sales

2.2M

10M

EPS

-0.005

Profit margin

-0.837

Employees

221

EBITDA

10M

1.8M

Dividends

By Dow Jones

Next Earnings

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

1.9M

26M

Previous open

-1.6

Previous close

0.84

Retractable Technologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Nov 2025, 23:51 UTC

Earnings

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 Nov 2025, 23:10 UTC

Earnings

DBS Third Quarter Net Dips 2.0%

5 Nov 2025, 22:55 UTC

Earnings

Arm Holdings 2Q Profit Climbs on Record Demand

5 Nov 2025, 22:23 UTC

Earnings

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 Nov 2025, 23:52 UTC

Earnings

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 Nov 2025, 23:49 UTC

Earnings

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 Nov 2025, 23:49 UTC

Earnings

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 Nov 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 Nov 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 Nov 2025, 23:12 UTC

Earnings

Nutrien 3Q Adj EPS 97c >NTR.T

5 Nov 2025, 23:11 UTC

Earnings

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 Nov 2025, 23:10 UTC

Earnings

Nutrien 3Q Sales $6.01B >NTR.T

5 Nov 2025, 23:10 UTC

Market Talk
Earnings

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 Nov 2025, 23:10 UTC

Earnings

Nutrien 3Q EPS 96c >NTR.T

5 Nov 2025, 23:04 UTC

Earnings

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 Nov 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 Nov 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 Nov 2025, 22:55 UTC

Earnings

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 Nov 2025, 22:51 UTC

Earnings

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 Nov 2025, 22:50 UTC

Earnings

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 Nov 2025, 22:44 UTC

Acquisitions, Mergers, Takeovers

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 Nov 2025, 22:43 UTC

Market Talk
Earnings

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 Nov 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 Nov 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 Nov 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 Nov 2025, 22:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 Nov 2025, 22:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 Nov 2025, 22:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Responds to Delaware Chancery Court Ruling

5 Nov 2025, 22:01 UTC

Earnings

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 Nov 2025, 22:01 UTC

Earnings

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Peer Comparison

Price change

Retractable Technologies Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Retractable Technologies Inc

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
help-icon Live chat